At present, many professionals believe that, marketing excellence is died in biopharma segment – they doesn’t add up what is needed in an adequate manner -estranges the other operations and don’t identify the prominent things to product success. Whether we define it strategic planning, commercial excellence is still to be adjudicated. No player has made the right nomenclature.


Who Upvoted this Story